<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"> <url> <loc>https://www.mskcc.org/news/targeted-drug-selpercatinib-greatly-reduces-risk-of-recurrence-in-early-stage-lung</loc>
 <news:news> <news:publication> <news:name>Memorial Sloan Kettering Cancer Center</news:name>
 <news:language>en</news:language>
</news:publication>
 <news:genres>Article</news:genres>
 <news:publication_date>2026-05-31</news:publication_date>
 <news:title>Targeted Drug Selpercatinib Greatly Reduces Risk of Recurrence in Early-Stage Lung Cancer </news:title>
 <news:keywords></news:keywords>
</news:news>
</url>
 <url> <loc>https://www.mskcc.org/news/targeted-therapy-shows-promising-results-against-rare-soft-tissue-sarcoma</loc>
 <news:news> <news:publication> <news:name>Memorial Sloan Kettering Cancer Center</news:name>
 <news:language>en</news:language>
</news:publication>
 <news:genres>Article</news:genres>
 <news:publication_date>2026-05-31</news:publication_date>
 <news:title>Targeted Therapy Shows Promising Results Against Rare Soft Tissue Sarcoma </news:title>
 <news:keywords></news:keywords>
</news:news>
</url>
 <url> <loc>https://www.mskcc.org/news/how-daraxonrasib-could-improve-pancreatic-cancer-treatment-offering-new-hope</loc>
 <news:news> <news:publication> <news:name>Memorial Sloan Kettering Cancer Center</news:name>
 <news:language>en</news:language>
</news:publication>
 <news:genres>Article</news:genres>
 <news:publication_date>2026-05-31</news:publication_date>
 <news:title>How Daraxonrasib Could Improve Pancreatic Cancer Treatment, Offering New Hope </news:title>
 <news:keywords></news:keywords>
</news:news>
</url>
</urlset>